Medication info
Loders 50 mg (Losartan Potassium)

Loders 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200500483 · Notified 2005.03.31 · Insurance code 660700320

Summary

Main use
Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric and adolescent patients aged 6 years and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus

  • Hypertension
  • kidney disease
View approved original text

This medication is used to treat hypertension and is particularly effective in preventing and treating kidney disease in patients with type 2 diabetes accompanying hypertension. By controlling hypertension, it prevents damage to blood vessels and organs and improves the decline in kidney function caused by diabetes. Therefore, it is a medication that aids in managing hypertension and related kidney complications.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric and adolescent patients aged 6 years and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Patients with allergy reactions to this medication or those with severely impaired liver function, patients with certain genetic disorders, and those with a history of angioedema should avoid this medication. Elderly patients, patients with impaired kidney function, and patients with high potassium levels in the blood need special caution when using this medication and should take it under the careful guidance of a physician. Symptoms such as dizziness or low blood pressure may occur during the use of this medication, so caution should be exercised when engaging in dangerous activities such as driving or operating machinery. Occasional side effects such as skin rash, headache, muscle pain, and cough may occur, and rarely serious allergic reactions or kidney function disorders may happen, so any unusual symptoms should be reported to medical personnel immediately. This medication may interact with other drugs, so if you are currently taking any other medications, you must inform your doctor or pharmacist and consult them. Particularly, caution is needed when taken together with potassium supplements or potassium-containing medications, as this may dangerously elevate blood potassium levels. It is important to regularly monitor blood pressure and conduct blood tests to check kidney function and electrolyte status during treatment. Pregnant or breastfeeding women are advised to avoid taking this medication, and if it must be taken, caution should be exercised after consulting with a doctor. This medication is not recommended for children, especially those under 6 years of age or for pediatric patients with severely impaired kidney function. In case of overdose, symptoms such as low blood pressure and bradycardia may occur, so strict adherence to the dosage is important, and if abnormal symptoms occur, an immediate visit to a medical institution is necessary. Finally, this medication should be stored out of reach of children and not transferred to other containers.

Side effects

Craniosynostosis, Anuria, Hypotension, Renal failure, Death, Muscle cramps, Low back pain, Leg pain, Dizziness, Congestion, Upper respiratory infection, Sinusitis, Nausea, Diarrhea, Indigestion, Cough, Sinus disorder, Pharyngitis, Myalgia, Insomnia, Headache, Weakness, Fatigue, Edema, Swelling, Abdominal pain, Chest pain, Lip swelling, Eyelid swelling, Facial rash, Palm exfoliation, Hemolysis, Facial edema, Fever, Orthostatic effect, Syncope, Angina, Second-degree atrioventricular block, Cerebrovascular accident, Myocardial infarction, Atrial fibrillation, Arrhythmia, Palpitations, Bradycardia, Tachycardia, Ventricular tachycardia, Ventricular fibrillation, Anorexia, Constipation, Toothache, Xerostomia, Flatulence, Gastritis, Vomiting, Anemia, Gout, Upper limb pain, Hip pain, Joint swelling, Knee pain, Muscle weakness, Arthralgia, Arthritis, Fibromyalgia, Anxiety, Anxiety disorder, Ataxia, Confusion, Depression, Nightmares, Sensory impairment, Decreased libido, Memory impairment, Migraine, Nervousness, Sensory abnormalities, Peripheral neuropathy, Panic disorder, Sleep disorder, Hypersomnolence, Tremors, Dyspnea, Bronchitis, Throat discomfort, Epistaxis, Rhinitis, Respiratory congestion, Chest discomfort, Hair loss, Dermatitis, Dry skin, Purpura, Erythema, Flushing, Photosensitivity reaction, Itching, Rash, Sweating, Urticaria, Blurry vision, Eye burning, Pain, Conjunctivitis, Dysgeusia, Tinnitus, Vision impairment, Erectile dysfunction, Nocturia, Frequent urination, Urethral infection, Angioedema, Vasculitis, Anaphylactoid syndrome, Liver function abnormality, Hepatitis, Intestinal vascular edema, Malaise, Thrombocytopenia, Myalgia, Weakness, Elevated creatine kinase, Rhabdomyolysis, Dysgeusia, Dry cough, Erythema multiforme, Hyperkalemia, Hyponatremia, Elevated ALT, Syncope, Loss of consciousness, Acute hepatitis, Fulminant hepatitis, Ventricular premature contraction, Hypoglycemia, Elevated serum creatinine, Shock symptoms due to blood pressure drop, Loss of consciousness due to blood pressure drop

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it should be stored at room temperature between 1°C and 30°C, avoiding extremely cold or hot places.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.